Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Shire Pharmaceuticals PLC (NasdaqNM:SHPGY)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Location
Hampshire Int'l Business Park
Hampshire RG24 8EP
Chineham, UK
Phone: (212) 704-8239
Fax: (212) 768-1025
Email: crosenfeld@uk.shire.com
Employees (last reported count): 1,023
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 5%
·Institutional: 22% (23% of float)
(256 institutions)
·Net Inst. Buying: 10.5M shares (+23.43%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Shire Pharmaceuticals Group PLC is an international specialty pharmaceutical company with a strategic focus on four therapeutic areas: central nervous system disorders, metabolic diseases, oncology and gastroenterology. The Company operates and manages its business in the United States, Europe and the rest of the world. Within these geographical segments, revenues are derived from sales of products by the Company's own sales and marketing operations, licensing and development fees and royalties. Shire Pharmaceuticals has its own direct marketing capability in the United States, Canada, the United Kingdom, the Republic of Ireland, France, Germany, Italy and Spain. The Company also covers other pharmaceutical markets indirectly through distributors.
More from Market Guide: Expanded Business Description

Financial Summary
SHPGY is a specialty pharmaceutical company focused on four therapeutic areas: central nervous system disorders, metabolic diseases, cancer and gastrointestinal disorders. For the six months ended 6/30/01, revenues rose 29% to $400.6 million. Net loss totaled $82.7 million vs. an income of $141.2 million. Revenues reflect an increased share of the U.S. ADHD market. Net loss reflects $177 million in charges related to the Biochem merger.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

James Cavanaugh, 63
Chairman
--  
Rolf Stahel, 56
CEO, Director
$971K
Angus Charles Russell, 44
Director, CFO
456K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:SHPGYAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$35.75 
Recent Price$43.42 
52-Week High
on 6-Nov-2000
$65.875
Beta0.92 
Daily Volume (3-month avg)1.09M
Daily Volume (10-day avg)778.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-24.5%
52-Week Change
relative to S&P500
+1.3%
Share-Related Items
Market Capitalization$6.85B
Shares Outstanding157.8M
Float149.9M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$7.09 
Earnings (ttm)$0.18 
Earnings (mrq)-$0.76 
Sales (ttm)$5.36 
Cash (mrq)$1.97 
Valuation Ratios
Price/Book (mrq)6.12 
Price/Earnings (ttm)241.22 
Price/Sales (ttm)8.09 
Income Statements
Sales (ttm)$675.4M
EBITDA (ttm)$32.9M
Income available to common (ttm)-$21.7M
Profitability
Profit Margin (ttm)-3.2%
Operating Margin (ttm)4.5%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-1.75%
Return on Equity (ttm)-2.26%
Financial Strength
Current Ratio (mrq)2.85 
Debt/Equity (mrq)0.01 
Total Cash (mrq)$303.3M
Short Interest
As of 8-Aug-2001
Shares Short3.49M
Percent of Float2.3%
Shares Short
(Prior Month)
3.47M
Short Ratio2.89 
Daily Volume1.21M
ADR Information
Shares/ADR3
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.